Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Nature Reviews. Immunology|January 24, 2009
The different faces of Notch in T-helper-cell differentiationDerk Amsen, Andrey Antov, Richard A FlavellTrends in Molecular Medicine|April 14, 2009
CD4 T-cell differentiation and inflammatory bowel diseaseLauren A Zenewicz, Andrey Antov, Richard A FlavellJournal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-toleranceAndrey Antov, Lili Yang, Monika Vig, et al.Patient Education and Counseling|July 22, 2020
Differences in cancer patients' and clinicians' preferences for disclosure of uncertain genomic tumor testing resultsAnny T Fenton, Eric C Anderson, Elizabeth Scharnetzki, et al.Immunity|July 31, 2007
Direct regulation of Gata3 expression determines the T helper differentiation potential of NotchDerk Amsen, Andrey Antov, Dragana Jankovic, et al.European Journal of Immunology|April 7, 2011
Alternative activation of macrophages by IL-4 requires SHIP degradationShelley B Weisser, Keith W McLarren, Nicole Voglmaier, et al.Proceedings of the National Academy of Sciences of the United States of America|June 6, 2009
Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysisDidi Matza, Abdallah Badou, Mithilesh K Jha, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2009
SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophilsEtsushi Kuroda, Victor Ho, Jens Ruschmann, et al.Psychology, Health & Medicine|May 20, 2020
The influence of uncertainty and uncertainty tolerance on attitudes and self-efficacy about genomic tumor testingEric C Anderson, Alexandra Hinton, Christine W Lary, et al.JCO Precision Oncology|October 11, 2021
Patients' Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology PracticesEric C Anderson, John DiPalazzo, Emily Edelman, et al.Pageof 2